Ovarian Cancer is Not a Silent Killer – Recognizing Its Symptoms Could Help Reduce Misdiagnosis and Late Detection
Barbara Goff, MD discusses ovarian cancer and how recognizing symptoms can lead to early detection and reduce misdiagnosis.
Barbara Goff, MD discusses ovarian cancer and how recognizing symptoms can lead to early detection and reduce misdiagnosis.
Overall survival longer with secondary cytoreductive surgery followed by platinum-based chemotherapy vs chemotherapy alone.
Findings seen in BRCA1 and BRCA2 mutation carriers; reduction greater with longer duration of use in BRCA1 carriers
A team of researchers sought to evaluate familial risks of developing breast cancer among women with a family history of cancers other than breast cancer.
Oral contraceptives have a lasting protective effect against ovarian and endometrial cancer, according to a new study.
The risk of developing benign ovarian cysts is up to 90% for premenopausal women and 75% for postmenopausal women.
And elevated CA125 indicates higher risk for other cancers, especially in women aged ≥50 years.
Correlation moderately attenuated after adjustment for health and ovarian cancer risk factors.
Novel noncontraceptive benefit seen for all intrauterine devices.
The sNDA is supported by data from the multicenter phase 2 QUADRA trial that evaluated the safety and activity of Zejula in 463 patients.